LITTLE GREEN PHARMA LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.13 AUD | 0.00% |
|
-3.70% | -7.14% |
| 05:58am | Little Green Pharma Welcomes Proposed Classification Downgrade of Cannabis in the US; Shares Rise 4% | MT |
| 04-17 | EARNINGS AND TRADING: Chill Brands shareholder seeks board ejections | AN |
Valuation
| Fiscal Period: Marzo | 2021 | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 131.1 | 116.5 | 39.2 | - | - |
| Enterprise Value (EV) 1 | 131.1 | 116.5 | 37.5 | 40.2 | 39.9 |
| P/E ratio | 4.72 x | -6.34 x | -65 x | -13 x | - |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | - | 1.53 x | 1.32 x | 1.1 x |
| EV / Revenue | - | - | 1.46 x | 1.35 x | 1.12 x |
| EV / EBITDA | - | - | 11 x | 201 x | 12.5 x |
| EV / FCF | - | - | -16.3 x | -16.1 x | 79.8 x |
| FCF Yield | - | - | -6.13% | -6.22% | 1.25% |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 187,275 | 240,211 | 301,551 | - | - |
| Reference price 2 | 0.7000 | 0.4850 | 0.1300 | 0.1300 | 0.1300 |
| Announcement Date | 30/08/21 | 30/06/22 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2021 | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | - | 25.6 | 29.8 | 35.5 |
| EBITDA 1 | - | - | 3.4 | 0.2 | 3.2 |
| EBIT 1 | - | - | 0.4 | -2.7 | 0.4 |
| Operating Margin | - | - | 1.56% | -9.06% | 1.13% |
| Earnings before Tax (EBT) 1 | - | - | -0.5 | -3 | 0.1 |
| Net income 1 | 24.6 | -18.29 | -0.5 | -3 | 0.1 |
| Net margin | - | - | -1.95% | -10.07% | 0.28% |
| EPS 2 | 0.1484 | -0.0765 | -0.002000 | -0.0100 | - |
| Free Cash Flow 1 | - | - | -2.3 | -2.5 | 0.5 |
| FCF margin | - | - | -8.98% | -8.39% | 1.41% |
| FCF Conversion (EBITDA) | - | - | - | - | 15.62% |
| FCF Conversion (Net income) | - | - | - | - | 500% |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 30/08/21 | 30/06/22 | - | - | - |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: Marzo | 2021 | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 1 | 0.7 |
| Net Cash position 1 | - | - | 1.7 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | 5 x | 0.2187 x |
| Free Cash Flow 1 | - | - | -2.3 | -2.5 | 0.5 |
| ROE (net income / shareholders' equity) | - | - | -0.3% | -2.1% | 0.1% |
| ROA (Net income/ Total Assets) | - | - | -0.3% | -2% | 0.1% |
| Assets 1 | - | - | 166.7 | 150 | 100 |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share 2 | - | - | 0 | -0.0100 | 0.0100 |
| Capex 1 | - | - | 1.4 | 1.1 | 1.1 |
| Capex / Sales | - | - | 5.47% | 3.69% | 3.1% |
| Announcement Date | 30/08/21 | 30/06/22 | - | - | - |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.13
AUD
Average target price
0.17
AUD
Spread / Average Target
+30.77%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.14% | 25.46M | |
| +39.33% | 6.11B | |
| -18.38% | 4.35B | |
| -9.17% | 3.18B | |
| +3.98% | 3.16B | |
| -3.41% | 2.51B | |
| +48.74% | 1.98B | |
| -4.82% | 1.74B | |
| -1.24% | 1.63B | |
| -8.96% | 1.6B |
- Stock Market
- Equities
- LGP Stock
- Financials Little Green Pharma Ltd
